Ignite Creation Date:
2024-05-06 @ 2:34 PM
Last Modification Date:
2024-10-26 @ 1:33 PM
Study NCT ID:
NCT04355520
Status:
UNKNOWN
Last Update Posted:
2020-04-21
First Post:
2020-04-20
Brief Title:
A Study of TQ-B3525 Tablets Combined With Fulvestrant Injection in Subjects With HR-positive HER2-negative and PIK3CA Mutation Advanced Breast Cancer
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Organization:
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-09
Completion Date Type:
ESTIMATED
First Submit Date:
2020-04-20
First Submit QC Date:
April 20 2020
Study First Post Date:
2020-04-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-20
Last Update Post Date:
2020-04-21
Last Update Post Date Type:
ACTUAL